摘要
目的对噻托溴铵联合舒利迭治疗老年重度持续支气管哮喘的临床观察的探讨。方法选取60例在我院接受住院治疗的患有重度持续支气管哮喘的老年患者，将其分为对照组和试验组，每组30例。对照组只使用舒利迭治疗，实验组使用噻托溴铵联合舒利迭对患者进行治疗，对其治疗一段时间后观察并比较两种不同方法治疗前、后的临床症状和疗效。结果试验组治疗后在胸闷、咳嗽程度、心率和脉压差等方面的评分平均都高于对照组各个情况的评分，差异具有统计学意义（P〈0．05）。试验组总有效率（90．00％）明显高于对照组总有效率（50．00％），差异具有统计学意义（P〈0．05）。结论噻托溴铵联合舒利迭治疗老年重度持续支气管哮喘具有很好的疗效，能改善患者的呼吸肌与平滑肌，使通气更加通畅，可在临床推广应用。
Objective To explore the clinical efficacy of tiotropium bromide combined with seretide in the treatment of elderly patients with severe persistent asthma. Methods 60 elderly patients with severe persistent asthma treated in our hospital were divided into a control group and an experimental group. The control group was treated with serretide, and the experimental group with tiotropium bromide and seretide. The clinical symptoms and efficacies of both groups before and after the treatment were observed and compared. Results The score of chest tightness, cough degree, heart rate, and pulse pressure were higher in the experimental group than in the control group, with statistical differences （P〈0.05）. The total effective rate of the experimental group （90.00%） was significantly higher than that of the control group （50.00%）, with statistical a diference （P〈0.05）. Conclusions Tiotropium bromide combined with seretide in the treatment of elderly patients with severe persistent asthma is quite effective, can make the patients breathe easily improving the function of smooth muscles and respiratory muscles, and is worth being clinically generalized.
出处
《国际医药卫生导报》
2014年第12期1743-1745,共3页
International Medicine and Health Guidance News
